Correction: CS Ratio is an immune-related prognostic biomarker for cervical cancer - Shi, Peiqin; Zhang, Wenwen; Yao, Qingqing; Yuan, Zhanna; Wang, Jiaqi; Yang, Ziye; Qu, Pengpeng (Frontiers in Oncology, 2025)